Von Willebrand disease overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Von Willebrand disease}} {{CMG}} ==Overview== '''Von Willebrand disease''' (vWD) is the most common hereditary coagulation abnormality described in humans, a..." |
George Leef (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
'''Von Willebrand disease''' (vWD) is the most common hereditary [[coagulation]] abnormality described in humans, although | '''Von Willebrand disease''' (vWD) is the most common hereditary [[coagulation]] abnormality described in humans. It affects up to 1% of the population, although most cases are mild. It arises from a qualitative or quantitative deficiency of [[von Willebrand factor]] (vWF), a [[Protein subunit|multimeric]] protein that is required for [[platelet]] adhesion . | ||
==References== | ==References== | ||
Revision as of 23:34, 8 June 2016
|
Von Willebrand disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Von Willebrand disease overview On the Web |
|
American Roentgen Ray Society Images of Von Willebrand disease overview |
|
Risk calculators and risk factors for Von Willebrand disease overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Von Willebrand disease (vWD) is the most common hereditary coagulation abnormality described in humans. It affects up to 1% of the population, although most cases are mild. It arises from a qualitative or quantitative deficiency of von Willebrand factor (vWF), a multimeric protein that is required for platelet adhesion .